Vertex
Dendreon's Infectious Influence on Biotechs
5:45PM 8/05/2011
Company News, Investing, Human Genome, NYSE, Stocks in the News, Market News, Investment
One of Thursday's hardest-hit stocks was Dendreon, maker of the prostate cancer vaccine Provenge, which plunged 67% after reporting disappointing results. But, weirdly, Debdreon's disease seemed to infect the entire sector, dragging down companies with proven drugs. Are biotechs bargains right now?
The Five Best Performing Biotech Stocks of 2011 -- So Far
7:30AM 4/01/2011
Company News, Investing, Health Care, Stock Picks, Investment
Pharmaceuticals are facing big patent cliff problems this year, but several biotechnology stocks have been doing quite well: Their biologic drugs command high prices, tend become blockbusters, and they are in far less danger from generic competition. Here are the big winners so far this year.
If you feel like the cost of everything is more expensive at the register these days, it's not your imagination. Even when the cost of goods and services has remained relatively flat, the associated sales and use taxes have continued to climb. Data released recently from Vertex, a privately-held...
Vertex Pharmaceutical shares soared 15% Wednesday as Wall Street cheered the results of a late-stage study of its new cystic fibrosis drug, an experimental treatment that targets the underlying cause of the disease rather than just its symptoms.
Global Pharmaceutical Sales Expected to Rise to $880 Billion in 2011
8:51AM 10/07/2010
Health Care, Johnson & Johnson, Pfizer, Bristol-Myers Squibb, Sanofi Aventis, Eli Lilly, Astrazeneca
Global pharmaceutical sales are expected to grow by 5% to 7% in 2011, thanks to robust growth in emerging markets, especially China, as well as new innovative treatments, and despite patent expirations and budget pressures in the developed world.
If you flip on the news or thumb through a newspaper these days, it's no secret that the federal government is facing a mounting deficit. Spending has outstripped revenues for years now, and the current recession has cut deeply into the biggest source of income: taxpayers.
What hasn't been touted...
News that Amylin Pharmaceuticals (AMLN) inked a billion-dollar development deal with Takeda Pharmaceutical for new obesity therapies was among the favorable developments in the sector on Monday that pushed several key stocks higher. Amylin shares were up nearly 10 percent in late trading after...
More Stories
Market Movers
| Symbol | Last | Change / % | Volume |
|---|
Most Actives
| 8.07 | -0.11 -1.34% | 254.23M | |
| 2.19 | +0.25 +12.89% | 122.18M | |
| 18.88 | -0.26 -1.33% | 109.55M | |
| 12.44 | -0.25 -1.97% | 52.49M |
% Gainers
| 31.68 | +7.78 +32.55% | 18.42M | |
| 89.96 | +13.57 +17.76% | 13.27M | |
| 2.19 | +0.25 +12.89% | 122.18M | |
| 10.50 | +1.10 +11.70% | 3.07M |
% Losers
DailyFinance Wire
- 4 Money-Etiquette Questions Answered
- Walmart's New Health Food Push: Is It Too Hard to Swallow?
- Newlyweds, Don't Let the IRS Spoil Your Honeymoon
- Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger
- Why Groupon Will Never Be Great Again
- Why Used Car Bargains Are Getting Harder to Find
- 5 Reasons Facebook Stock May Be a Better Buy Than You Think
Newswire
- Staff at The Sun tabloid arrested in bribe...
- Greece's grim choice: deep budget cuts or...
- Greek premier defends bailout deal, painful...
- Faces beyond the numbers of long-term...
- Obama budget: New spending with recycled tax...
- Obama budget seeks to boost trade enforcement
- As Facebook IPO nears, the case for dull stocks
- Turbo-traders take Bank of America for a ride
- Getting paid $35,000 to short sell
- What the $26B settlement means for you
- Investing your emergency cash: Return vs. risk
- First Premier's $400-a-year credit card
- Big banks' bloated mortgage tab
- Fewer young adults hold jobs than ever before
- Government assistance expands
- Bob Rodriguez: The best advice I ever got
- 24/7 Wall St. Top Analyst Calls of the Week (AONE, ALU, AMSC, NLY, AAPL, CSCO, COH, CSTR, COP, DLR, IBM, LF, MMM, M, OPEN, POST, SIRI, SOHU, TRLG, ZOLT)
- The Force: Star Wars Franchise Worth Over $30 Billion and Growing
- 24/7 Wall St. Closing Bell (COP, GILD, AMSC, MA, COH, LNKD, ATVI, CPST, GPRE, KONA, TRLG, LGF, MOVE, NBL, PCYC, ALU, FLIR, RUTH, FSLR, CIE, TBAC, RPXC, AMRS)
- Mid-day Movers (CIE, AMRS, IPSU, MOVE, LNKD)
- Petrobras Shares Volatile on $225 Billion Development Plan (PBR)
- Morning Movers (CIE, ALU, LNKD, AMRS, XIDE)
- AEP Dividend Growth Still Looks Safe Ahead (AEP)
- Arch Coal Tumbles on Earnings, Forecast (ACI, ANR, PCX, BTU, CNX)
Follow Us
